Cell Innovation Partners
Overview
Cell Innovation Partners is a healthcare venture capital firm established as a joint venture between Reprocell and SBI Shinsei Bank, focusing on investments in regenerative medicine and stem cell technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Symic Bio | Apr 2019 | Series B Extension | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cell Innovation Partners based?
Cell Innovation Partners is headquartered in Tokyo, Japan.
When was Cell Innovation Partners founded?
Cell Innovation Partners was founded in 2014.
How many portfolio companies does Cell Innovation Partners have?
Cell Innovation Partners has 1 portfolio company in Caplight's dataset.
What are some companies in Cell Innovation Partners's portfolio?
Recent investments visible on Caplight include Symic Bio.
What was Cell Innovation Partners's most recent investment?
Cell Innovation Partners's most recent investment on Caplight was in Symic Bio in 2019.
What sectors does Cell Innovation Partners focus on?
Cell Innovation Partners focuses on Healthcare & Life Sciences.
What company stages does Cell Innovation Partners focus on?
Stage focus information for Cell Innovation Partners is not publicly available.
What is Cell Innovation Partners's AUM?
Cell Innovation Partners's assets under management are estimated between $6.0M and $8.0M.